presented by James Latronica, DO
June 8, 2023 — 7:00 - 8:30 pm


1.5 Category 1-A AOA or AMA PRA Category 1 Credits Available

XWaiverCoursePOMA is excited to provide a free webinar for health professionals who are interested in learning more about buprenorphine prescribing, dosing and monitoring, as well as regulatory changes that went into effect in January 2023.  Click here to view the event flyer.

The "Buprenorphine Prescribing Crash Course" will be presented live via Zoom by POMA Trustee James Latronica, DO on June 8, 2023 from 7:00 -  8:30 pm.  CME credit will be awarded for registrants who participate and attest - please allow one month for CME processing.  Click here to register.  The Zoom webinar link will be sent upon completion of registration.

This educational event is a collaborative effort coordinated by POMA, the Pennsylvania Medical Society, the Pennsylvania Society of Addiction Medicine and the University of Pittsburgh School of Medicine.  The free, live webinar will be recorded and made available for purchase later this summer.

Disclosure Statement
No one involved in the planning or delivery of this activity has any relevant financial relationships to disclose.  This activity was designed to address DEA recommendations on core training elements for Substance Use Disorders. 

CME Information
ACCME Accreditation Statement — This activity has been planned and implemented in accordance with the  Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint  providership of the American Society of Addiction Medicine (ASAM) and the University of Pittsburgh, the Pennsylvania Society of Addiction Medicine, and the Pennsylvania Medical Society. The American Society of  Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement — The American Society of Addiction Medicine designates this live activity  for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with  the extent of their participation in the activity.
AOA Credit Designation Statement — POMA is accredited by the American Osteopathic Association (AOA) to  provide osteopathic continuing medical education for physicians. POMA designates this live internet activity for  a maximum of 1.5 Category 1-A AOA CME credits. Physicians should claim only the credit commensurate with  the extent of their participation in the educational activity. 

New Education Requirements for DEA License Renewal
Authored by POMA President Lisa Witherite-Rieg, DO
Published April 7, 2023 in POMA's Under the DOme publication

Beginning June 27, 2023, when you renew your DEA license, you will be asked to attest to having completed eight (8) hours of education on “treatment and management of patients with opioid or other substance use disorders.” Current holders of DEA licenses may have received this notice.

There are some exceptions, but the majority of prescribers who hold a DEA license will need to complete a one-time attestation for completion of the required education. This new requirement is a result of the Consolidated Appropriations Act of 2023, when Congress eliminated the "DATA-Waiver Program.”

This is good news for our patients who wish to seek treatment of substance use disorder. This is also good news for Osteopathic physicians who care for these patients and wish to treat them!

Even better news…

If you have maintained your unrestricted Pennsylvania Osteopathic license since 2017, you have already completed the required opioid education under the Mandated Act 124 of 2017. If you have completed DATA-Waiver education, that counts toward this requirement. If you have participated in POMA’s Substance Use Disorder webinar series last fall (a member benefit), you completed up to 6 hours of opioid education! There are opportunities for this required education at POMA's Annual Clinical Assembly, as well as on-demand courses in the POMA catalog for purchase.

POMA is ahead of the game and we have you covered!

Opioid CME Requirement for PA License Renewal

Pennsylvania has a two-year licensure cycle which runs from November 1 of an even year through October 31 of the next event year.  For osteopathic physicians with an unrestricted license, the State Board of Osteopathic Medicine requires 2 hours of board-approved education in pain management, the identification of addiction, or the practices of prescribing or dispensing of opioids.  These credits can be either Category 1 or Category 2.  For osteopathic physicians with an active/retired license that maintain their DEA registration, the State Board requires the same 2 hours of board-approved opioid education.  Osteopathic physicians with an active/retired license that do not maintain their DEA registration do not need 2 hours of opioid education.

Learn more about Pennsylvania's osteopathic renewal process on the Pennsylvania State Board of Osteopathic Medicine website.